Vahan Ajamian, Managing Director of Analyst Relations for Medmen Enterprises Inc. (OTCQB: MMNFF) joins our podcast to discuss the company's approach to cannabis in Canada and the United States.
Focused on uranium exploration in Namibia, Deep Yellow Ltd. (OTCQB: DYLLF) is a development company listed on the Australian Stock Exchange. John Borshoff joins the podcast to provide an overview of the company and explain why the company chose to cross trade on the OTCQB Venture Market.
SinglePoint, Inc. (OTCQB: SING) focuses on acquiring companies that will benefit from the injection of growth capital and technology integration. Gregory Lambrecht, CEO of SinglePoint chats with us about the company's acquisition philosophy.
Zach Bair, CEO of VNUE, Inc. (OTCQB: VNUE) joins our podcast to explain how the company and its products support artists and provide transparency to the music industry.
Gary Macleod, CEO and James Whelan, CTO of AlphaPoint Technology Inc. (OTCQB: APPO), a technology holding and software application development company, stopped by our offices in New York during Consensus 2018 to discuss the company's initiatives.
Cornerstone Metals (OTCQB: CCCCF) is a Vancouver based mineral exploration company that's focused on advancing the Carlin Vanadium Project in North Central Nevada. Paul Cowley, President & CEO of Cornerstone joins our podcast to provide an update on the project and the company.
James Thompson CEO of Callitas Health Inc. (OTCQB: MPHMF), an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, joins our OTCQB podcast to update listeners on the company's product development.
Bravada Gold Corporation (OTCQB: BGAVF) is a Nevada-focused exploration and development company, exploring for precious metals in well-established gold trends in one of the world's best gold jurisdictions. CEO, Joseph A. Kizis, Jr. joins our podcast to discuss the company's initiatives.
Humanigen, Inc. (OTCQB: HGEN) is a biopharmaceutical company pursuing cutting-edge science to develop our proprietary monoclonal antibodies for immunotherapy and oncology treatments. Joining our podcast today is Cameron Durrant, Chairman and CEO.
CanAlaska Uranium Ltd. (TSX-V: CVV; OTCQB: CVVUF; Frankfurt: DH7N) holds interests in approximately 500,000 hectares (1.2 million acres), one of the largest land positions in Canada's Athabasca Basin region, dubbed the "Saudi Arabia of Uranium" due to the area's large, high-grade uranium resources. CanAlaska's strategic holdings have attracted major international mining companies: Cameco, Denison, KORES, and KEPCO to explore the company's projects. Joining us today is Peter Dasler, President and CEO.
ADM Tronics Unlimited, Inc. (OTCQB: ADMT) is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house. ADMT has three areas of activity: Proprietary Medical Devices; Medical Device Design, Engineering, Regulatory and Manufacturing Services; and, Eco-Friendly, Water-Based Formulations.
Joining today is Andre DiMino, CEO of ADM Tronics.
Quaterra Resources Inc. (OTCQB: QTRRF) is a junior exploration and development company with a focus on its copper projects in Nevada including McArthur, Yerington, Bear and Wassuk properties.
In this interview, we spoke with Gerald Denis Prosalendis, the company’s President, COO & Director. For more information about the company, please visit their company page here.
GFG Resources (OTCQB: GFGSF) is a North American precious metals exploration company headquartered in Saskatoon, Saskatchewan, Canada, whose shares trade on the TSX Venture Exchange (GFG) and on the OTCQB (GFGSF). The Company controls 100% of the Rattlesnake Hills Gold Project, a district scale gold exploration project located approximately 100 kilometres southwest of Casper, Wyoming, U.S. The geologic setting, alteration and mineralization seen in the Rattlesnake Hills are similar to other gold deposits of the Rocky Mountain alkaline province which, collectively, have produced over 50 million ounces of gold. The Company also controls 100% of two large and highly prospective gold properties west of the prolific gold district of Timmins, Ontario, Canada. The Ontario properties are comprised of the 44,500-hectare Pen Gold Project (including the West Porcupine property) and the 12,000-hectare Dore Gold Project.
Mason Res Corp (OTCQB: MSSNF) is focused on copper development in the USA, with its flagship asset the 100%-owned Ann Mason Project in Nevada. Ann Mason is currently at a PEA level and is ranked as the 4th largest undeveloped copper porphyry resource in Canada/USA. The Company also holds a 100%-interest in the Lordsburg property, an earlier-stage copper-gold porphyry project, located in New Mexico. Mason's strong financial position and high-quality asset portfolio provide it with a solid foundation and flexibility for growth.
Kane Biotech Inc. (OTCQB: KNBIF) is a Canadian-based technology company engaged in the development and commercialization of products that prevent and remove microbial biofilms.
Chilean Metals Inc. (OTCQB: CMETF), formerly International PBX Ventures Ltd., is an exploration-stage company. The Company is engaged in exploring copper and gold on its various properties located in Chile and Nova Scotia.
First Cobalt (OTCQB: FTSSF) is focused on building a diversified global portfolio of assets that are highly leveraged to the cobalt market. Our projects include interests proximal to several major copper-cobalt ("Cu-Co") operations in the Central African Copperbelt in the DR Congo - and In Canada, an interest in the former producing Keeley-Frontier mine, a high-grade silver-cobalt mine (produced over 3.3 million pounds of cobalt and 19.1 million ounces of silver 1908 - 1965).
Wize Pharma (OTCQB: WIZPD) is a clinical-stage biopharmaceutical company currently focused on the treatment of ophthalmic disorders, including Dry Eye Syndrome. Wize Pharma has inlicensed certain rights to purchase, market, sell and distribute a formula known as LO2A, a drug developed for the treatment of Dry Eye Syndrome, and other ophthalmological illnesses, including Sjorgen's Syndrome and Conjunctivochalasis.
Highland Copper Company Inc. (OTCQB: HDRSF) is a Canadian copper development company focused on advancing sediment-hosted copper projects in the Copper Range District of the Upper Peninsula of Michigan, U.S.A. The Copper Range district is well known for hosting significant concentrations of copper and silver in numerous deposits. During its productive period, from 1845 to 1995, the area produced in excess of 15 billion pounds of copper.
As we approach the end of the year, Mary Twiss, AVP, OTC Markets Group Corporate Services thanks those OTCQB companies that joined us this year and chats about the market this year. Make sure to join us again in 2018.
Envision Solar (OTCQB: EVSI) is a sustainable technology innovation company based in San Diego. Desmond Wheatley, President & CEO chats with us about how the company invents, designs, engineers and manufactures renewable energized products for 3 major market verticals.
How can branded packaging help you stand out from the competition? Nicholas Kovacevich, CEO of KUSH BOTTLES INC (OTCQB: KSHB) explains the company's unique approach to packaging products and solutions.
Is there a faster way to identifying the root cause of a patient's excessive bleeding? Philip Young, President & CEO of Exactus, Inc. (OTCQB: EXDI) explains how the company's Point-of-Care (POC) diagnostics for measuring proteolytic enzymes in the blood are designed to help physicians.
IEH Corporation (OTCQB: IEHC) recently celebrated its 75th anniversary. David Offerman, the IEH's President & CEO chats with us about how the company, which develops and manufactures printed circuit connectors for high performance applications, is innovating and expanding into new markets.
How can we make prescriptions more affordable? That's the question that drives OptimizeRx Corp. (OTCQB: OPRX), a health technology software company that is revolutionizing the point of care experience. Listen in to learn more as we chat with William Febbo the company's CEO.